NumFin

Dongwha Pharm.Co.,Ltd

Sümbol: 000020.KS

KSC

8750

KRW

Turuhind täna

  • 8.7584

    P/E suhe

  • 0.0387

    PEG suhe

  • 242.53B

    MRK Cap

  • 0.02%

    DIV tootlus

Dongwha Pharm.Co.,Ltd (000020-KS) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Dongwha Pharm.Co.,Ltd (000020.KS) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Dongwha Pharm.Co.,Ltd fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920072006

balance-sheet.row.cash-and-short-term-investments

087234.2107694.5121509.6
120330.8
120018.9
103681.9
129681.4
66750.4
50909.4
35678.7
31184.1
34139.2
37054.4
20482.6
16779
57455.8
60390.3

balance-sheet.row.short-term-investments

014917.173347.461030
61734.4
82239.8
63067.4
98093.3
31020
6020
3055.5
3020
16020
1920
2341.6
7262.8
52778.5
50961.6

balance-sheet.row.net-receivables

074484.372638.262266.7
62773.2
81837.6
80247
68212.4
58164.1
57954.4
56486.7
55138.9
55501.9
63104.1
61067.2
51125.3
52688.3
54745.5

balance-sheet.row.inventory

070697.246783.636244
39504.2
33430.8
43717.6
36606.2
26577.3
26150.9
28382.3
30436.8
31594.4
32162.7
39026.8
37446.8
26225.3
17717

balance-sheet.row.other-current-assets

05284.4411.1178.3
135.2
169.7
240.9
0
0
0
0
0.2
0.2
0.2
0.2
0.2
0.2
0.2

balance-sheet.row.total-current-assets

0237700227527.5220198.6
222743.5
235457
227887.5
234500
151491.8
135014.7
120547.7
116759.9
121235.7
132321.4
120576.9
105351.2
136369.7
132852.9

balance-sheet.row.property-plant-equipment-net

0188330.5151152.7142850.5
130950.8
99214.8
96772.5
103746.3
142170.9
151777.3
161854.1
171902.3
183871.6
188283.8
149283.6
154301.7
71262.7
53292.6

balance-sheet.row.goodwill

020483.34555.84555.8
4555.8
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

035994.511146.713582.4
12417
5464.7
5581.2
6137
6442.3
6431.8
7107.6
8265.3
4194.7
5222.6
5292.3
4574.2
1109.4
904.5

balance-sheet.row.goodwill-and-intangible-assets

056477.815702.518138.2
16972.8
5464.7
5581.2
6137
6442.3
6431.8
7107.6
8265.3
4194.7
5222.6
5292.3
4574.2
1109.4
904.5

balance-sheet.row.long-term-investments

073880.1-16766.6-9737.1
-11957
-52000.1
-26567.7
-76135.4
-9620.9
10668.9
14883.6
11452.3
-1684.3
11036.8
10032.5
6383.5
-42829.7
-41631.3

balance-sheet.row.tax-assets

06241.864006194.2
3965.6
5652.4
3858.4
883.8
3100.3
7274.4
5624.5
4117.8
16666.9
2566.9
1265
74.1
0
52196.6

balance-sheet.row.other-non-current-assets

02342.277120.470160
71132.1
82239.8
63067.4
98093.3
31020
6020
3055.5
3667.9
0
0
37559.6
38307.1
54510.9
333.1

balance-sheet.row.total-non-current-assets

0327272.4233609227605.8
211064.3
140571.6
142711.8
132725.1
173112.7
182172.3
192525.4
199405.6
203049
207110.1
203433
203640.5
84053.3
65095.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0564972.4461136.5447804.5
433807.8
376028.6
370599.2
367225.1
324604.5
317187
313073.1
316165.5
324284.7
339431.5
324009.9
308991.7
220423
197948.4

balance-sheet.row.account-payables

031412.322231.817118.7
18522.2
17322.5
29965.4
21776.3
25671.9
17169.6
17980.1
18495.6
17645.5
22057
17923.1
16552.6
6778.5
4789.1

balance-sheet.row.short-term-debt

020371.54619.76418.5
11614.3
1793.2
0
0
0
2000
4000
4000
10000
18500
24250
31626
5825
8596.4

balance-sheet.row.tax-payables

02224.55443.87788.1
8607.2
10332.8
5101.6
16384
6055.3
3657.9
3216.6
6404.9
11585.5
3065.5
5896.5
1799.7
13505.5
7065.7

balance-sheet.row.long-term-debt-total

016127.72044.35055.7
4074.5
5116
0
0
0
0
0
2000
0
10000
18500
0
336.8
1161.8

Deferred Revenue Non Current

011756.122.940.5
16775.1
0
0
0
0
0
0
0
0
30162.2
6771.7
0
10013
7792

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

052909.447508.85988.9
5940.2
6927.8
30832.9
38940.4
29780.1
0
0
0
0
0
40484.5
44506.4
0
0

balance-sheet.row.total-non-current-liabilities

0515236900.921210
23631.6
19439.3
12400.3
9563.8
16227.2
17920.2
14432.2
15561.8
14690.1
21947.4
27437.3
7427.7
8703.3
11894.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

011756.13686.83514.6
5888.8
6909.2
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0157656.982463.287671.3
91125.6
75154
73198.6
70280.4
71679.2
87069.3
83347.3
88934.4
97290
109807.6
110094.9
100112.7
41281.1
36950.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

027931.527931.527931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5

balance-sheet.row.retained-earnings

034480.7311972.2290329
270244.8
198844.7
195595.4
239897.6
197195.9
174195.4
173103.7
170147.3
169661.3
172752.3
119334.3
113223.5
86087.7
67944

balance-sheet.row.accumulated-other-comprehensive-income-loss

0293197.7274806261485.5
246425.1
236228.7
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

016169.6-250309.3-232811.1
-213345.8
-162130.2
73564.1
29115.6
27797.9
27990.9
28690.6
29152.3
29401.9
28940.1
66649.3
67724.1
65122.8
65122.7

balance-sheet.row.total-stockholders-equity

0371779.5364400.4346934.9
331255.5
300874.6
297091
296944.7
252925.3
230117.7
229725.8
227231.1
226994.7
229623.9
213915
208879.1
179141.9
160998.2

balance-sheet.row.total-liabilities-and-stockholders-equity

0564972.4461136.5447804.5
433807.8
376028.6
370599.2
367225.1
324604.5
317187
313073.1
316165.5
324284.7
339431.5
324009.9
308991.7
220423
197948.4

balance-sheet.row.minority-interest

03553614272.813198.3
11426.7
0
309.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0407315.5378673.3360133.2
342682.2
300874.6
297400.7
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

088797.156580.951292.9
49777.4
30239.7
36499.8
21957.9
21399.1
16688.9
17939.1
14472.3
14335.7
12956.8
12374.1
13646.4
9948.8
9330.3

balance-sheet.row.total-debt

048255.4666411474.1
15688.8
6909.2
0
0
0
2000
4000
6000
10000
28500
42750
31626
6161.8
9758.1

balance-sheet.row.net-debt

0-24061.8-27683.1-49005.5
-42907.6
-30869.9
-40614.5
-31588.2
-35730.4
-42889.4
-28623.2
-22164.1
-8119.2
-6634.4
24609
22109.8
1484.4
329.5

Rahavoogude aruanne

Dongwha Pharm.Co.,Ltd finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920072006

cash-flows.row.net-income

027438.321591.219582.8
28715.1
9393.9
10068.1
47009
26254.3
5608.7
4937.2
1011.9
1311.2
17679.2
5427.2
6717.4
21495.4
8065.2

cash-flows.row.depreciation-and-amortization

01389612509.112093
10707
11484.7
11357.2
11501.1
11743.7
11864.5
12636.7
12532.2
12201
12457
18732.6
15228.1
3473.8
3320.2

cash-flows.row.deferred-income-tax

0-41674.500
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

076.100
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-19296.7-18086.3-4035.4
11363.9
-17040.7
-23576
-41682.8
-25687.1
-4417.2
-8506.8
-592.6
-2306.8
14883.4
-12149.8
5381.5
-7219.1
7894.5

cash-flows.row.account-receivables

0-4300.7-5636750.8
24046
-1972.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-12307.6-14104.5-1443.4
-5580.6
4451.4
-11789
-13584.4
-2881.9
-684
-1945.2
1157.7
568.3
4965.7
-3170.4
3925.9
-8508.4
-706.3

cash-flows.row.account-payables

02801.95014.1-1532.4
436.5
-12642.6
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-5490.3-3359.9-1810.4
-7538
-6877.1
-11787
-28098.3
-22805.2
-3733.2
-6561.6
-1750.3
-2875
9917.8
-8979.4
1455.5
1289.2
8600.8

cash-flows.row.other-non-cash-items

048727.413206.78390.8
1442.2
9447.2
-2209.4
-33347.3
13171.2
6777.2
4447.6
-4746.4
14021.3
1224.4
6577.9
2593.4
5905.3
3906

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-26345.6-20091.5-24774.2
-30114.7
-5505.8
-3701.4
-3370.3
-2503.1
-1225.9
-1684.7
-5881.6
-6844.8
-9783.2
-12571.8
-35004.1
-22170.3
-6479.9

cash-flows.row.acquisitions-net

0-18896.42599.2-2070.4
-18180.3
15195.4
243.6
-1000
-1408.9
-358.9
-408.1
-1675.9
0
-430.4
408.9
2044.8
464.5
-181.7

cash-flows.row.purchases-of-investments

0-27918.4-143537.9-105847.9
-82249.3
-101955.1
-40607.6
-85300.1
-30500
0
-3035.5
-3020
-14100
-22262.3
-2130.5
-53276.7
-117573.3
-81980.3

cash-flows.row.sales-maturities-of-investments

076140.5114969.9104048.7
100748.9
81117.8
61524.4
21041.8
2508.8
223.2
50
16039
0
22097.7
7313.8
68968.7
115209.5
69012.8

cash-flows.row.other-investing-activites

0-117.32788.33230
3964.6
-30.7
-241.6
84938.6
1474.3
381.9
-20.8
2616.8
0
948.8
-1391.5
1175.4
124.3
-545.4

cash-flows.row.net-cash-used-for-investing-activites

02863-43272-25413.9
-25830.8
-11178.4
17217.4
16310
-30429
-979.7
-5099.1
8078.4
-20944.8
-9429.4
-8371.2
-16091.8
-23945.4
-20174.5

cash-flows.row.debt-repayment

0-13500-7500-7800
-1000
0
0
0
-2000
-2000
-2000
-8000
-18500
-27029
-35000
-2336.8
-3596.4
-3596.4

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
-876.5
0
-2354.4
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-4982.2-4982.2-4969.4
-3312.9
-3312.9
-4141.2
-3043.1
-2213.2
-2234.5
-1955.2
-2234.5
-2793.1
-2793.1
-2793.1
-4189.7
-3351.7
-2793.1

cash-flows.row.other-financing-activites

024347.7469.23986.5
-1145.1
-1624.6
310
0
0
0
0
4000
0
10000
36201.3
-8753.2
2487
610.7

cash-flows.row.net-cash-used-provided-by-financing-activities

05865.5-12013-8782.9
-5458.1
-4937.6
-3831.2
-3919.6
-4213.2
-6588.9
-3955.2
-6234.5
-21293.1
-19822.2
-1591.8
-15279.6
-4461.2
-5778.8

cash-flows.row.effect-of-forex-changes-on-cash

074.9-68.248.8
-122.1
-4.3
0.2
-12.6
1
1.7
-1.2
-4.1
-4
1
0
0
0
0

cash-flows.row.net-change-in-cash

037970-26132.51883.2
20817.2
-2835.3
9026.3
-4142.2
-9159
12266.2
4459.1
10044.9
-17015.2
16993.4
8624.8
-1451.1
-4751.2
-2767.4

cash-flows.row.cash-at-end-of-period

072317.134347.160479.6
58596.4
37779.2
40614.5
31588.2
35730.4
44889.4
32623.2
28164.1
18119.2
35134.4
18141
9516.2
4677.4
9428.6

cash-flows.row.cash-at-beginning-of-period

034347.160479.658596.4
37779.2
40614.5
31588.2
35730.4
44889.4
32623.2
28164.1
18119.2
35134.4
18141
9516.2
10967.3
9428.6
12196

cash-flows.row.operating-cash-flow

029166.629220.836031.2
52228.2
13285
-4360.1
-16520
25482.2
19833.1
13514.7
8205.1
25226.8
46244
18587.8
29920.3
23655.3
23185.9

cash-flows.row.capital-expenditure

0-26345.6-20091.5-24774.2
-30114.7
-5505.8
-3701.4
-3370.3
-2503.1
-1225.9
-1684.7
-5881.6
-6844.8
-9783.2
-12571.8
-35004.1
-22170.3
-6479.9

cash-flows.row.free-cash-flow

028219129.311257
22113.5
7779.1
-8061.5
-19890.3
22979.1
18607.2
11829.9
2323.6
18382
36460.8
6016
-5083.7
1485
16706

Kasumiaruande rida

Dongwha Pharm.Co.,Ltd tulud muutusid võrreldes eelmise perioodiga NaN%. 000020.KS brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920072006

income-statement-row.row.total-revenue

0361108.6340426.3293018.1
272075.4
307150
306602.6
258881.6
237470.8
223201.3
213472.1
220240.6
223372
234562
215279.4
145115.2
175119.8
148738.6

income-statement-row.row.cost-of-revenue

0176983.8159436.1143671.1
133409.4
185418.3
190699.4
150798
134293.4
126621.9
118268.2
124566.9
124599.3
126631.7
121482.7
79597.7
77654.1
76044.8

income-statement-row.row.gross-profit

0184124.7180990.3149347
138666
121731.7
115903.2
108083.6
103177.4
96579.4
95203.9
95673.7
98772.7
107930.3
93796.7
65517.4
97465.6
72693.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-342332.755166.453095.9
47771.6
46097.2
400.8
-1669.5
21730.5
133.8
-2801.1
-2303.2
-2310.2
-5680.1
-4513.8
-2105.4
-4623.2
-3074.3

income-statement-row.row.operating-expenses

0342332.7151075.2126848.5
115508.7
111814
104674.1
97096.3
91918.1
91766.4
87409.6
93611.5
88769.8
82308.6
83479.5
53129.2
63920.8
58522.5

income-statement-row.row.cost-and-expenses

0342332.7310511.2270519.6
248918.1
297232.3
295373.4
247894.3
226211.5
218388.3
205677.9
218178.4
213369.1
208940.3
204962.2
132726.9
141574.9
134567.4

income-statement-row.row.interest-income

03252.82387.71067.9
1839.7
1942.7
2116.7
1166.8
856.9
786.1
896.4
926.2
1376.7
669.9
989.5
1008.7
4055.6
2834.7

income-statement-row.row.interest-expense

0308370383.1
292.2
207
-3685.5
-108755.7
7.7
136.7
231.6
384.3
1056
1757.6
2446.4
1303
447.7
624.8

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

018179.7-6829.54030.9
10484.9
-487.1
3313.3
54231.4
1234.6
1187.6
-507
-354.9
-1573.3
-6588.6
-1658.8
-412.6
-673.7
-651.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-342332.755166.453095.9
47771.6
46097.2
400.8
-1669.5
21730.5
133.8
-2801.1
-2303.2
-2310.2
-5680.1
-4513.8
-2105.4
-4623.2
-3074.3

income-statement-row.row.total-operating-expenses

018179.7-6829.54030.9
10484.9
-487.1
3313.3
54231.4
1234.6
1187.6
-507
-354.9
-1573.3
-6588.6
-1658.8
-412.6
-673.7
-651.5

income-statement-row.row.interest-expense

0308370383.1
292.2
207
-3685.5
-108755.7
7.7
136.7
231.6
384.3
1056
1757.6
2446.4
1303
447.7
624.8

income-statement-row.row.depreciation-and-amortization

0138961398114940.8
12080.6
11484.7
11357.2
11501.1
11743.7
11864.5
12636.7
12532.2
12201
12457
18732.6
15228.1
3473.8
3320.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

018775.929915.122496.4
23153.4
17095
11225.8
10987.3
11259.3
4813
7794.3
2062.2
10002.9
25621.7
10317.2
12388.3
33544.8
14171.3

income-statement-row.row.income-before-tax

036955.623085.526527.3
33638.3
16607.9
14539.1
65218.7
35655.1
6000.6
5401.9
889.9
8429.6
19033.1
5430.2
11975.6
32871.2
13519.8

income-statement-row.row.income-tax-expense

08718.51494.36944.5
4923.2
7214
4470.9
18209.7
9400.8
392
464.7
-122
7118.4
1353.9
3
5258.2
11375.8
5454.6

income-statement-row.row.net-income

027438.320383.517870.4
28507.7
9402.2
10068.5
47009
26254.3
5608.7
4937.2
1011.9
1311.2
17679.2
5427.2
6717.4
21495.4
8065.2
Sarnased aktsiad
Sind võib huvitada ka:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Korduma kippuv küsimus

Mis on Dongwha Pharm.Co.,Ltd (000020.KS) koguvara?

Dongwha Pharm.Co.,Ltd (000020.KS) koguvara on 564972408621.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.523.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 101.776.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.076.

Mis on ettevõtte kogutulu?

Kogutulu on 0.052.

Mis on Dongwha Pharm.Co.,Ltd (000020.KS) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 27438289760.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 48255358875.000.

Mis on tegevuskulude arv?

Tegevuskulud on 342332682000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.